Loftus, Peter

Welcome to the Loftus, Peter section. Here, you may find and purchase Loftus, Peter posters for any taste.

Whaler's Cove Morning Fog Art Print 30 in. x 24 in.

Accurately selected Loftus, Peter posters decorate rooms, create cosiness and comfort. The most pleasant thing about posters is that you may choose any topic and color solution to your liking. Our Loftus, Peter gallery features posters of various color and topical solutions.

Forest Labs Scraps Heart-Imaging Agent Obtained In Acquisition - Wall Street Journal

Forest Labs Scraps Heart-Imaging Agent Obtained In Acquisition Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES Forest Laboratories Inc. (FRX) has discontinued development of an experimental agent for cardiovascular imaging procedures. In an annual report filed Friday with the US Securities and Exchange Commission, ... Forest Labs scraps agent obtained through mergerMarketWatch all 2 news articles »

more..

Top Priest: 'Did Best I Could' - Wall Street Journal

Wall Street Journal

Top Priest: 'Did Best I Could' Wall Street Journal By PETER LOFTUS PHILADELPHIA—A monsignor accused of covering up allegations that Roman Catholic priests sexually abused children testified at his trial Wednesday he had limited authority to take action against the priests he supervised, ... and more »

more..

J&J's Simponi Helps Colitis Patients In Clinical Trial - Wall Street Journal

J&J's Simponi Helps Colitis Patients In Clinical Trial Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES Johnson & Johnson (JNJ) said its drug Simponi improved symptoms in a majority of patients with an inflammatory-bowel disease in a new clinical trial. Simponi, which was introduced in 2009, is currently approved to ... and more »

more..

Abbott Bid For US Approval Of New Use For Humira Is Delayed - Wall Street Journal

Abbott Bid For US Approval Of New Use For Humira Is Delayed Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES Abbott Laboratories (ABT) has encountered a delay in its bid for US regulatory approval to expand the uses of its blockbuster anti-inflammatory drug Humira to include treatment of the bowel disease ulcerative ... and more »

more..

Pfizer Recalls More Than 650000 Bottles Of Advil Liqui-Gels - Wall Street Journal

Pfizer Recalls More Than 650000 Bottles Of Advil Liqui-Gels Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) recently recalled more than 650000 bottles of Advil pain-relief medicine due to the potential for a strong odor in the product. New York-based Pfizer issued the voluntary recall of eight lots of ... and more »

more..

After a Sentence to Write Sentences, Dr. Bodnar Ends a Legal Chapter - Wall Street Journal

After a Sentence to Write Sentences, Dr. Bodnar Ends a Legal Chapter Wall Street Journal By PETER LOFTUS When former pharmaceutical executive Andrew G. Bodnar pleaded guilty to white-collar crime in 2009, the judge didn't throw the book at him—he ordered him to write one. Reflect upon "the criminal behavior in this case so that others ... and more »

more..

Dyer signs new QPR deal - ESPN

ESPN

Dyer signs new QPR deal ESPN By ESPN staff Queens Park Rangers midfielder Kieron Dyer has signed a new one-year deal with the Loftus Road club - despite playing just three minutes this season. Dyer, 33, broke his foot during QPR's opening day defeat to Bolton at Loftus Road last ... Hall heads list of Loftus Rd leaversClubcall Dyer deal surpriseSetanta Sports Ireland KIERON DYER SIGNS ON BUT ADEL TAARABT TO LEAVE QPRDaily Star The Sport Review -7M SPORTS all 52 news articles »

more..

Study: J&J's Zytiga Can Eliminate Some Prostate Tumors - Wall Street Journal

Study: J&J's Zytiga Can Eliminate Some Prostate Tumors Wall Street Journal By JENNIFER CORBETT DOOREN And PETER LOFTUS WASHINGTON—A study looking at small group of men with prostate cancer showed the use of Johnson & Johnson's Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated ... and more »

more..

Drug Makers Continue Shift To Targeted Cancer Therapies - Wall Street Journal

Drug Makers Continue Shift To Targeted Cancer Therapies Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells. and more »

more..

Dendreon: SEC Opens Probe, Possibly Tied To Provenge Disclosures - Wall Street Journal

Dendreon: SEC Opens Probe, Possibly Tied To Provenge Disclosures Wall Street Journal By Peter Loftus Of DOW JONES NEWSWIRES Dendreon Corp. (DNDN) said the US Securities and Exchange Commission has begun a formal investigation, which may be related to shareholder lawsuits alleging the company misled investors about prostate-cancer drug ... and more »

more..